BlakleyBW, MagitA. 2009. Letter to the Editor. Response to: The role of tonsillectomy in reducing recurrent pharyngitis: a systematic review, from Jeremy Hornibrook. Otolaryngol Head Neck Surg, 141:155–156.
2.
BilimoriaKY, BentremDJ, KoCY, StewartAK, WichesterDP, TalamontiM, SturgeonC. 2007. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg, 246:375–384.
3.
WhiteML, GuagerPG, DohertyGM. 2007. Central lymph node dissection in differentiated thyroid cancer. World J Surg, 31:895–904.
NoguchiS, MurakamiN. 1987. The value of lymph node dissection in patients with differentiated thyroid cancer. Surg Clin North Am, 67:251–261.
6.
BonnetS, HartlD, LeboulleuxS, BaudinE, LumbrosoJD, Al GhuzlanA, ChamiL, SchlumbergerM, TravagliJP. 2009. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab, 94:1162–1167.
7.
DuranteC, HaddyN, BaudinE, LeboulleuxS, HartlD, TravagliJP, CaillouB, RichardM, LumbrosoJD, De VathaireF, SchlumbergerM. 2006. Long term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab, 91:2892–2899.
8.
SadowskiBM, SnyderSK, LairmoreTC. 2009. Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery, 146:696–705.
9.
ThomuschO, SekullaC, TimmermannW, NeumannHJ, KruseE, MühligHP, HamelmannWH, RichterCh, VoßJ, DralleH. 2003. Intraoperative neuromonitoring in thyroid surgery—results of the German Prospective Multicentre Study. Eur Surg, 35:240–245.
10.
ItoY, JikuzonoT, HigashiyamaT, AsahiS, TomodaC, TakamuraY, MiyaA, KobayashiK, MatsuzukaF, KumaK, MiyauchiA. 2006. Clinical significance of lymph node metastases of thyroid papillary carcinoma located in one lobe. World J Surg, 30:1821–1828.
11.
MachensA, HolzhausenHJ, DralleH. 2005. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer, 103:2269–2273.
12.
LeboulleuxS, RubinoC, BaudinE, CaillouB, HartlDM, BidartJM, TravagliJP, SchlumbergerM. 2005. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastasis and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab, 90:5723–5729.
13.
SosaJA, BowmanHM, TielschJM, PoweNR, GordonTA, UdelsmanR. 1998. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg, 228:320–330.
14.
MazzaferriEL, DohertyGM, StewardDL. 2009. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid, 19:683–689.
15.
HartlDM, TravagliJP, LeboulleuxS, BaudinE, BrasnuDF, SchlumbergerM. 2005. Current concepts in the management of unilateral recurrent laryngeal nerve paralysis after thyroid surgery. J Clin Endocrinol Metab, 90:3084–3088.
16.
MiccoliP, PincheraA, MaterazziG, BiaginiA, BertiP, FavianaP, MolinaroE, ViolaD, EliseiR. 2009. Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy. J Clin Endocrinol Metab, 94:1618–1622.
